Reshaping acute brain failure and delirium care delivery
Prolira is committed to enabling early and effective treatment of acute encephalopathy and delirium. Every year, 20 million patients are at risk of acute brain failure in EU and US hospitals, which leads to long-term cognitive impairment, extended hospital stays, and increased healthcare costs.
Prolira’s DeltaScan® Brain State Monitor is the world’s first EEG bedside device with a validated proprietary algorithm to support clinicians in their quest to optimize patient recovery.
.png)
By applying Prolira’s technology, we improve care for many patients and reduce bed days. Ultimately reducing long-term cognitive decline.
Each job position provides equal opportunities irrespective of race, ethnicity, and gender. The best person for the job is all that counts.
Driven by a commitment to sustainable innovation, Prolira diligently strives to bring about tangible growth both within the organization and across its supply chain.
Through product development, we actively work on reducing plastic waste by introducing recycled plastics in our next generation of products.